CA2813472A1 - Encres amorphes cristallines a solidification rapide - Google Patents

Encres amorphes cristallines a solidification rapide Download PDF

Info

Publication number
CA2813472A1
CA2813472A1 CA 2813472 CA2813472A CA2813472A1 CA 2813472 A1 CA2813472 A1 CA 2813472A1 CA 2813472 CA2813472 CA 2813472 CA 2813472 A CA2813472 A CA 2813472A CA 2813472 A1 CA2813472 A1 CA 2813472A1
Authority
CA
Canada
Prior art keywords
group
phase change
ink
change ink
crystalline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2813472
Other languages
English (en)
Inventor
Gabriel Iftime
Jennifer L. Belelie
Daryl W. Vanbesien
Peter G. Odell
Kentaro Morimitsu
Naveen Chopra
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xerox Corp
Original Assignee
Xerox Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xerox Corp filed Critical Xerox Corp
Priority to CA 2813472 priority Critical patent/CA2813472A1/fr
Publication of CA2813472A1 publication Critical patent/CA2813472A1/fr
Abandoned legal-status Critical Current

Links

Landscapes

  • Inks, Pencil-Leads, Or Crayons (AREA)
  • Ink Jet (AREA)
CA 2813472 2012-04-26 2013-04-19 Encres amorphes cristallines a solidification rapide Abandoned CA2813472A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA 2813472 CA2813472A1 (fr) 2012-04-26 2013-04-19 Encres amorphes cristallines a solidification rapide

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/547,271 2012-07-12
CA 2813472 CA2813472A1 (fr) 2012-04-26 2013-04-19 Encres amorphes cristallines a solidification rapide

Publications (1)

Publication Number Publication Date
CA2813472A1 true CA2813472A1 (fr) 2013-10-26

Family

ID=49475990

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2813472 Abandoned CA2813472A1 (fr) 2012-04-26 2013-04-19 Encres amorphes cristallines a solidification rapide

Country Status (1)

Country Link
CA (1) CA2813472A1 (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9732080B2 (en) 2006-11-03 2017-08-15 Vertex Pharmaceuticals Incorporated Azaindole derivatives as CFTR modulators
US10071979B2 (en) 2010-04-22 2018-09-11 Vertex Pharmaceuticals Incorporated Process of producing cycloalkylcarboxamido-indole compounds
US10081621B2 (en) 2010-03-25 2018-09-25 Vertex Pharmaceuticals Incorporated Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide
US10206877B2 (en) 2014-04-15 2019-02-19 Vertex Pharmaceuticals Incorporated Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9732080B2 (en) 2006-11-03 2017-08-15 Vertex Pharmaceuticals Incorporated Azaindole derivatives as CFTR modulators
US10081621B2 (en) 2010-03-25 2018-09-25 Vertex Pharmaceuticals Incorporated Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide
US10071979B2 (en) 2010-04-22 2018-09-11 Vertex Pharmaceuticals Incorporated Process of producing cycloalkylcarboxamido-indole compounds
US10206877B2 (en) 2014-04-15 2019-02-19 Vertex Pharmaceuticals Incorporated Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases

Similar Documents

Publication Publication Date Title
CA2775192C (fr) Compositions d'encre solides comprenant des esters amorphes de l'acide citrique
CA2813480C (fr) Compositions d'encre a changement de phase comportant des composes sulfones cristallins et derives de celles-ci
US9938422B2 (en) Phase change inks comprising crystalline amides
US9051486B2 (en) Phase change ink components and methods of making the same
CA2774656A1 (fr) Encres a changement de phase et methodes de fabrication connexes
US20130284054A1 (en) Rapid solidifying crystalline-amorphous inks
US9528015B2 (en) Phase change ink compositions comprising crystalline diurethanes and derivatives thereof
CA2813358C (fr) Compositions d'encre amorphe cristalline a cristallisation rapide et leurs methodes de fabrication
CA2813484C (fr) Compositions d'encre a changement de phase comportant des ethers aromatiques
US9228101B2 (en) Rapidly crystallizing phase change inks and methods for forming the same
CA2813360C (fr) Encres a changement de phase comprenant des pigments organiques
CA2813472A1 (fr) Encres amorphes cristallines a solidification rapide
US8647423B2 (en) Phase change inks comprising fatty acids
US8882897B2 (en) Phase change inks comprising aromatic diester crystalline compounds
US9580615B2 (en) Phase change inks comprising inorganic nucleating agents
CA2838482A1 (fr) Materiaux amorphes a utiliser dans les encres de changement de phase

Legal Events

Date Code Title Description
FZDE Dead

Effective date: 20160420